MITOMYCIN, IFOSFAMIDE AND CISPLATIN IN NON-SMALL CELL LUNG-CANCER - TREATMENT GOOD ENOUGH TO COMPARE

被引：114

作者：

CULLEN, MH ^{[1
]}

JOSHI, R ^{[1
]}

CHETIYAWARDANA, AD ^{[1
]}

WOODROFFE, CM ^{[1
]}

机构：

[1] MANOR HOSP,WALSALL WS2 9PS,ENGLAND

来源：

关键词：

D O I：

10.1038/bjc.1988.219

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：359 / 361

页数：3

共 9 条

[1] VINDESINE, CISPLATIN, AND BLEOMYCIN COMBINATION CHEMOTHERAPY IN NON-SMALL CELL LUNG-CANCER - SURVIVAL AND QUALITY-OF-LIFE
BAKKER, W
VANOOSTEROM, AT
AARONSON, NK
VANBREUKELEN, FJM
BINS, MC
HERMANS, J
[J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (08): : 963 - 970
[2] CHEMOTHERAPY OF NON-SMALL CELL LUNG-CANCER - A REAPPRAISAL AND A LOOK TO THE FUTURE
BAKOWSKI, MT
CROUCH, JC
[J]. CANCER TREATMENT REVIEWS, 1983, 10 (03) : 159 - 172
[3] CHETIYAWARDANA AD, 1985, 4TH P WORLD C LUNG C, V4, P106
[4] GIRON CG, 1987, CANCER TREAT REP, V71, P851
[5] GOLDIN A, 1982, SEMIN ONCOL, V9, P14
[6] KRIS MG, 1986, CANCER TREAT REP, V70, P1091
[7] KRIS MG, 1985, 4TH P WORLD C LUNG C, V4, P39
[8] OBRIEN MER, 1987, 4TH P EUR C CLIN ONC, V4, P281
[9] 1979, HDB REPORTING RESULT, P48